Literature DB >> 25998844

Variants of Base Excision Repair Genes MUTYH , PARP1 and XRCC1 in Alzheimer's Disease Risk.

Dominik Kwiatkowski1, Piotr Czarny, Piotr Galecki, Agnieszka Bachurska, Monika Talarowska, Agata Orzechowska, Kinga Bobińska, Anna Bielecka-Kowalska, Tadeusz Pietras, Janusz Szemraj, Michael Maes, Tomasz Sliwinski.   

Abstract

BACKGROUND: Many clinical studies have shown that oxidative stress pathways and the efficiency of the oxidative DNA damage base excision repair (BER) system are associated with the pathogenesis of Alzheimer's disease (AD). Reduced BER efficiency may result from polymorphisms of BER-related genes. In the present study, we examine whether single nucleotide polymorphisms (SNPs) of BER genes are associated with increased risk of AD.
METHODS: SNP genotyping was carried out on DNA isolated from peripheral blood mononuclear cells obtained from 120 patients with AD and 110 healthy volunteers. Samples were genotyped for the presence of BER-related SNPs, i.e. XRCC1-rs1799782, rs25487; MUTYH-rs3219489, and PARP1-rs1136410.
RESULTS: We found a positive association between AD risk and the presence of G/A genotype variant of the XRCC1 rs25487 polymorphism [odds ratio (OR) = 3.762, 95% CI: 1.793-7.891]. The presence of the A/A genotype of this polymorphism reduced the risk of AD (OR = 0.485, 95% CI: 0.271-0.870). In cases of the PARP1 gene rs1136410 polymorphism, we observed that the T/C variant increases (OR = 4.159, 95% CI: 1.978-8.745) while the T/T variant reduces risk (OR = 0.240, 95% CI: 0.114-0.556) of AD.
CONCLUSIONS: We conclude that BER gene polymorphisms may play an important role in the etiology of AD. Diagnosing the presence or absence of particular genetic variants may be an important marker of AD. Further research on a larger population is needed. There is also a need to examine polymorphisms of other BER in the context of AD risk.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25998844     DOI: 10.1159/000381985

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  7 in total

Review 1.  Genome instability in Alzheimer disease.

Authors:  Yujun Hou; Hyundong Song; Deborah L Croteau; Mansour Akbari; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2016-04-20       Impact factor: 5.432

Review 2.  The base excision repair process: comparison between higher and lower eukaryotes.

Authors:  Nagham Nafiz Hindi; Noha Elsakrmy; Dindial Ramotar
Journal:  Cell Mol Life Sci       Date:  2021-11-03       Impact factor: 9.261

Review 3.  Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.

Authors:  Showkat Ul Nabi; Andleeb Khan; Ehraz Mehmood Siddiqui; Muneeb U Rehman; Saeed Alshahrani; Azher Arafah; Sidharth Mehan; Rana M Alsaffar; Athanasios Alexiou; Bairong Shen
Journal:  Oxid Med Cell Longev       Date:  2022-05-14       Impact factor: 7.310

4.  Single-Nucleotide Polymorphisms of Genes Involved in Repair of Oxidative DNA Damage and the Risk of Recurrent Depressive Disorder.

Authors:  Piotr Czarny; Dominik Kwiatkowski; Monika Toma; Piotr Gałecki; Agata Orzechowska; Kinga Bobińska; Anna Bielecka-Kowalska; Janusz Szemraj; Michael Berk; George Anderson; Tomasz Śliwiński
Journal:  Med Sci Monit       Date:  2016-11-20

5.  Investigation of base excision repair gene variants in late-onset Alzheimer's disease.

Authors:  Tugce Ertuzun; Asli Semerci; Mehmet Emin Cakir; Aysegul Ekmekcioglu; Mehmet Oguz Gok; Daniela T Soltys; Nadja C de Souza-Pinto; Ugur Sezerman; Meltem Muftuoglu
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

6.  Role of physical exercise in Alzheimer's disease.

Authors:  Wei-Wei Chen; Xia Zhang; Wen-Juan Huang
Journal:  Biomed Rep       Date:  2016-02-22

7.  Modulation of the Apurinic/Apyrimidinic Endonuclease Activity of Human APE1 and of Its Natural Polymorphic Variants by Base Excision Repair Proteins.

Authors:  Olga A Kladova; Irina V Alekseeva; Murat Saparbaev; Olga S Fedorova; Nikita A Kuznetsov
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.